The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(hex-1-ynyl)-2-(1-(2-morpholinoacetyl)piperidin-4-ylamino)benzamide ID: ALA5093202
PubChem CID: 166631843
Max Phase: Preclinical
Molecular Formula: C24H34N4O3
Molecular Weight: 426.56
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCC#Cc1ccc(NC2CCN(C(=O)CN3CCOCC3)CC2)c(C(N)=O)c1
Standard InChI: InChI=1S/C24H34N4O3/c1-2-3-4-5-6-19-7-8-22(21(17-19)24(25)30)26-20-9-11-28(12-10-20)23(29)18-27-13-15-31-16-14-27/h7-8,17,20,26H,2-4,9-16,18H2,1H3,(H2,25,30)
Standard InChI Key: UAEKBIRAHWVBAW-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 33 0 0 0 0 0 0 0 0999 V2000
2.7349 -19.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7338 -20.1473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4418 -20.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1515 -20.1468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1487 -19.3242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4400 -18.9189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0271 -18.9193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0269 -18.1022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3195 -19.3281 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4376 -18.1017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1441 -17.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4416 -21.3735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4339 -22.1880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4261 -23.0051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7145 -23.4070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7067 -24.2241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9951 -24.6259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8550 -18.1013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5593 -17.6941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5611 -16.8766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8523 -16.4679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1418 -16.8768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2692 -16.4685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9765 -16.8777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2698 -15.6513 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6846 -16.4697 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3878 -16.8835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0937 -16.4789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0986 -15.6614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3914 -15.2501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6793 -15.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 2 0
7 9 1 0
6 10 1 0
11 10 1 0
3 12 1 0
12 13 3 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
11 18 1 0
11 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
26 27 1 0
26 31 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 426.56Molecular Weight (Monoisotopic): 426.2631AlogP: 2.06#Rotatable Bonds: 7Polar Surface Area: 87.90Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.75CX LogP: 2.19CX LogD: 2.18Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: -1.35
References 1. Xu S, Guo A, Chen NN, Dai W, Yang HA, Xie W, Wang M, You QD, Xu XL.. (2021) Design and synthesis of Grp94 selective inhibitors based on Phe199 induced fit mechanism and their anti-inflammatory effects., 223 [PMID:34174740 ] [10.1016/j.ejmech.2021.113604 ]